Cancer cachexia impacts almost 90% of people living with pancreatic cancer. Learn more about this condition in this Q&A with Nicolas Clifford, PanCAN’s manager of research and education communication.

A new study coordinated by Dr. Salvatore Cortellino and Professor Antonio Giordano, President of the Sbarro Health Research Organization (SHRO) and molecular oncologist at Temple University and the ...

The metabolism–cancer axis is currently at a critical inflection point. A landmark August 2025 JAMA Oncology study reported a 17% reduction in overall ...

The Pancreatic Cancer Action Network is holding a webinar “Nutrition and Pancreatic Cancer: Weight Loss, Enzymes and More” to talk about common nutritional challenges related to pancreatic cancer.

Phase 2a trial of atebimetinib + mGnP in first-line pancreatic cancer patients, well above the standard of care benchmark from GnP of 35% overall survival; On track for expanded pancreatic cancer ...

MARCH 4, 2026, NEW YORK - Ludwig Cancer Research is proud to announce that Director of the Oxford Branch of the Ludwig Institute for Cancer Research ...

The team is led by Leanne Li of The Francis Crick Institute in London, England. Her research combines cancer biology and neuroscience to investigate how cancer communicates with peripheral nerves ...

Detailed price information for Artelo Biosciences Inc (ARTL-Q) from The Globe and Mail including charting and trades.

Cancer remains a leading cause of morbidity and mortality, although cancer survivorship has increased impressively in the past decades. Patients with cancer often face cardiovascular complications, ...

University of Houston researchers have identified a key cellular pathway involved in muscle wasting caused by pancreatic cancer, offering new insights into potential therapies. Cancer cachexia is not ...

Across disciplines, therapeutic areas and even continents, Pfizer scientists have been working to advance understanding of – and potential treatments for – cachexia, a complex metabolic condition ...